Robert A. Beardsley, Ph.D. President & CEO

Al has over 30 years experience in drug development and company-building, and has served as our Chief Executive Officer since 2024. Prior to joining Cirius, he served in various roles, including most recently as Executive Chair and Chief Operating Officer of Galera Therapeutics 2010 to 2024. Al was the Chief Executive Officer at Metabolic Solutions Development Corporation from 2009 until 2010, and at Kereos from 2003 until 2009, and the acting Chief Executive Officer at Metaphore Pharmaceuticals, Inc. in 2002. He has also served in various management roles at Confluence Life Sciences, bioStrategies Group, Vector Securities International, Enzyme Organics and Mobil Oil. Al serves or has served on a number of public and private boards including Metallomix, Senari Pharma, Euclises, Epigenetx, KemPharm, Kereos, CollaGenex Pharmaceuticals, Bioseek, and Metaphore Pharmaceuticals. 

Al received his Ph.D. in Biochemical Engineering and B.S. in Chemical Engineering from the University of Iowa and an M.B.A. in Finance from the University of Chicago.